
In attempted bear market brushback, SMA player Scholar Rock nabs $205M raise on open-label extension data
One month after telling the SEC it would lay off about a fourth of its staff, Scholar Rock is following the blueprint laid out by other public biotechs during the bear market: raising some big cash on the heels of a data readout.
The Cambridge, MA-based company announced Friday morning it plans to raise $205 million in a public offering after touting two-year Phase II data in spinal muscular atrophy as positive, also on Friday. The figure represents more money than Scholar Rock’s market cap at Thursday’s closing, which clocked in at $171.6 million.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.